Invention Grant
- Patent Title: Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats
-
Application No.: US15881148Application Date: 2018-01-26
-
Publication No.: US10905757B2Publication Date: 2021-02-02
- Inventor: Janet K. Yamamoto
- Applicant: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
- Applicant Address: US FL Gainesville
- Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
- Current Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC.
- Current Assignee Address: US FL Gainesville
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Main IPC: A61K39/21
- IPC: A61K39/21 ; A61K39/12 ; C07K14/005 ; C12N7/00 ; C07K16/10 ; A61K45/06 ; G01N33/569 ; A61K39/00
Abstract:
The subject invention concerns methods and materials for inducing an immune response in an animal or person against an immunodeficiency virus, such as HIV, SIV, or FIV. In one embodiment, a method of the invention comprises administering one or more antigens and/or immunogens to the person or animal wherein the antigen and/or immunogen comprises one or more evolutionarily conserved epitopes of immunodeficiency viruses. In one embodiment, the epitope is one that is conserved between HIV and SIV, or between HIV and FIV. In another embodiment, the epitope is one that is conserved between HIV, SIV, and FIV.
Public/Granted literature
- US20180228890A1 CROSS-REACTIVE T CELL EPITOPES OF HIV, SIV, AND FIV FOR VACCINES IN HUMANS AND CATS Public/Granted day:2018-08-16
Information query
